| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Isometheptene Mucate (200 mg) |
|
7492-31-1 |
詳細(xì)
|
| Isonaringin (30 mg) ((RS)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) |
|
14259-46-2 |
詳細(xì)
|
| Isopropamide Iodide (200 mg) |
|
71-81-8 |
詳細(xì)
|
| Isopropyl 4-acetylbenzoate (COLD SHIPMENT REQUIRED) (25 mg) (Isopropyl 4-acetylbenzoate) |
|
220089-22-5 |
詳細(xì)
|
| Isopropyl Diphenylphosphorylpentanoate |
|
2088449-88-9 |
詳細(xì)
|
| Isopropyl Isostearate (3 x 1 mL) |
|
68171-33-5 |
詳細(xì)
|
| Isopropyl Myristate (5 x 100 mg) |
|
110-27-0 |
詳細(xì)
|
| Isopropyl Palmitate (500 mg) |
|
142-91-6 |
詳細(xì)
|
| Isoproterenol Hydrochloride (125 mg) |
|
51-30-9 |
詳細(xì)
|
| Isopteropodine (20 mg) |
|
5171-37-9 |
詳細(xì)
|
| Isorhamnetin (30 mg) |
|
480-19-3 |
詳細(xì)
|
| Isorhamnetin-3-O-Rutinoside (15 mg) |
|
604-80-8 |
詳細(xì)
|
| Isostearyl Isostearate (1 mL) |
|
41669-30-1 |
詳細(xì)
|
| Isradipine (200 mg) |
|
75695-93-1 |
詳細(xì)
|
| Ivabradine Bisbenzazepine Analog (25 mg) (3,3'-(propane-1,3-diyl)bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one)) |
|
2731089-65-7 |
詳細(xì)
|
| Ivermectin (200 mg) |
|
70288-86-7 |
詳細(xì)
|
| Ixabepilone (100 mg) |
|
219989-84-1 |
詳細(xì)
|
| Jujuboside A (15 mg) |
|
55466-04-1 |
詳細(xì)
|
| Kaempferol (15 mg) (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one) |
|
520-18-3 |
詳細(xì)
|
| Kaempferol-3-O-Robinoside-7-O-Glucoside (20 mg) |
|
114924-89-9 |
詳細(xì)
|
| Kanamycin Sulfate (200 mg) |
|
5965-95-7 |
詳細(xì)
|
| Kawain (200 mg) |
|
500-64-1 |
詳細(xì)
|
| Ketamine Related Compound A (50 mg) (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol) |
|
6740-87-0 |
詳細(xì)
|
| Ketoconazole (200 mg) |
|
65277-42-1 |
詳細(xì)
|
| Ketotifen Fumarate (100 mg) |
|
34580-14-8 |
詳細(xì)
|
| Ketovarenicline Trifluoroacetate (25 mg) (rel-(6S,10R)-8-(2,2,2-trifluoroacetyl)-1,6,7,8,9,10-hexahydro-2H-6,10-methanoazepino[4,5-g]quinoxalin-2-one) |
|
357426-10-9 |
詳細(xì)
|
| Levocabastine Hydrochloride (50 mg) |
|
79547-78-7 |
詳細(xì)
|
| Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) |
|
80139-91-9 |
詳細(xì)
|
| Levocetirizine Amide (75 mg) |
|
909779-33-5 |
詳細(xì)
|
| Levomenol (100 mg) |
|
23089-26-1 |
詳細(xì)
|
| Levomethorphan Solution (3 x 1.2 mL) (0.1 mg/mL 3-Methoxy-17-methylmorphinan in methanol) |
|
|
詳細(xì)
|
| Levonorgestrel (125 mg) |
|
797-63-7 |
詳細(xì)
|
| Levothyroxine (500 mg) |
|
51-48-9 |
詳細(xì)
|
| Lidocaine Hydrochloride (150 mg) |
|
6108-05-0 |
詳細(xì)
|
| Magnesium Carbonate (2 g) |
|
23389-33-5 |
詳細(xì)
|
| Magnesium Chloride (1 g) |
|
7791-18-6 |
詳細(xì)
|
| Magnesium Citrate (500 mg) |
|
3344-18-1 |
詳細(xì)
|
| Magnesium Hydroxide (1 g) |
|
1309-42-8 |
詳細(xì)
|
| Magnesium Oxide (500 mg) |
|
1309-48-4 |
詳細(xì)
|
| Magnesium Phosphate (2 g) (AS) |
|
7757-87-1 |
詳細(xì)
|
| Linalyl Acetate (0.3 mL) |
|
115-95-7 |
詳細(xì)
|
| Linarin (50 mg) |
|
480-36-4 |
詳細(xì)
|
| Lincomycin Hydrochloride (200 mg) |
|
7179-49-9 |
詳細(xì)
|
| Linoleyl Alcohol (5 X 30 mg) |
|
506-43-4 |
詳細(xì)
|
| Liothyronine Sodium (COLD SHIPMENT REQUIRED) (200 mg) |
|
55-06-1 |
詳細(xì)
|
| Lithium Carbonate (300 mg) |
|
554-13-2 |
詳細(xì)
|
| Lithol Rubine BK (100 mg) (2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(E)-2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1)) |
|
5281-04-9 |
詳細(xì)
|
| Lomustine (200 mg) |
|
13010-47-4 |
詳細(xì)
|
| Lomustine Related Compound D (25 mg) (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) |
|
54749-91-6 |
詳細(xì)
|
| Loperamide Hydrochloride (200 mg) |
|
34552-83-5 |
詳細(xì)
|
| Loperamide Related Compound F (25 mg) (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate) |
|
181112-35-6 |
詳細(xì)
|
| Lopinavir (350 mg) |
|
192725-17-0 |
詳細(xì)
|
| Lorazepam Related Compound A (25 mg) (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one) |
|
2848-96-6 |
詳細(xì)
|
| Lorazepam Related Compound B (25 mg) (2-Amino-2',5-dichlorobenzophenone) |
|
2958-36-3 |
詳細(xì)
|
| Lorazepam Related Compound C (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde) |
|
93955-15-8 |
詳細(xì)
|
| Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid) |
|
54643-79-7 |
詳細(xì)
|
| Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) |
|
773871-49-1 |
詳細(xì)
|
| Loxapine N-Oxide (25 mg) (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide) |
|
25967-34-4 |
詳細(xì)
|
| Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) |
|
3454-96-4 |
詳細(xì)
|
| Loxapine Succinate (125 mg) |
|
27833-64-3 |
詳細(xì)
|
| Lumefantrine (100 mg) |
|
82186-77-4 |
詳細(xì)
|
| Lycopene Preparation (500 mg) |
|
502-65-8 |
詳細(xì)
|
| Lynestrenol (20 mg) ((17alpha) -19-Norpregn-4-en-20-yn-17-ol) |
|
52-76-6 |
詳細(xì)
|
| Mafenide Acetate (200 mg) |
|
13009-99-9 |
詳細(xì)
|
| Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) |
|
3240-35-5 |
詳細(xì)
|
| Magaldrate (200 mg) (PLANNED TO BE DISCONTINUED) |
|
74978-16-8 |
詳細(xì)
|
| Leflunomide Related Compound A (100 mg) (4-(trifluoromethyl)aniline) |
|
455-14-1 |
詳細(xì)
|
| Lenalidomide Open Ring (25 mg) (2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanediamide) |
|
2197414-55-2 |
詳細(xì)
|
| Letrozole (200 mg) |
|
112809-51-5 |
詳細(xì)
|
| Leuprolide Acetate (1.97 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) |
|
74381-53-6 |
詳細(xì)
|
| Levamisole Hydrochloride (125 mg) |
|
16595-80-5 |
詳細(xì)
|
| Levobunolol Hydrochloride (200 mg) |
|
27912-14-7 |
詳細(xì)
|
| Lanolin Alcohols (5 g) |
|
8027-33-6 |
詳細(xì)
|
| Lansoprazole Related Compound B (25 mg) (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate) |
|
1288338-69-1 |
詳細(xì)
|
| Lauric Acid (500 mg) |
|
143-07-7 |
詳細(xì)
|
| Lauroyl Polyoxylglycerides 1500 (500 mg) |
|
121548-04-7 |
詳細(xì)
|
| Lauroyl Polyoxylglycerides 300 (500 mg) |
|
12737-91-6 |
詳細(xì)
|
| Lauryl Alcohol (125 mg) |
|
112-53-8 |
詳細(xì)
|
| L-Alanyl-L-Glutamine (200 mg) |
|
39537-23-0 |
詳細(xì)
|
| L-Cysteine Hydrochloride (600 mg) |
|
7048-04-6 |
詳細(xì)
|
| L-Fucose (200 mg) |
|
2438-80-4 |
詳細(xì)
|
| L-Glutamic Acid Hydrochloride (100 mg) |
|
138-15-8 |
詳細(xì)
|
| L-Histidine (200 mg) |
|
71-00-1 |
詳細(xì)
|
| L-Lysine Acetate (200 mg) |
|
57282-49-2 |
詳細(xì)
|
| L-Lysine Hydrochloride (200 mg) |
|
657-27-2 |
詳細(xì)
|
| L-Methionine (200 mg) |
|
63-68-3 |
詳細(xì)
|
| L-Theanine (200 mg) |
|
3081-61-6 |
詳細(xì)
|
| L-Tryptophan (200 mg) |
|
73-22-3 |
詳細(xì)
|
| L-alpha-Glycerophosphorylethanolamine (25 mg) |
|
33049-08-0 |
詳細(xì)
|
| Labetalol Hydrochloride (200 mg) |
|
32780-64-6 |
詳細(xì)
|
| Lactase (200 mg) (COLD SHIPMENT REQUIRED) |
|
9031-11-2 |
詳細(xì)
|
| Lactitol (500 mg) |
|
81025-04-9 |
詳細(xì)
|
| Lactose Monohydrate (500 mg) |
|
64044-51-5 |
詳細(xì)
|
| Lamivudine-trans (25 mg) (4-amino-1-[(2RS,5RS)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 1-[(2RS,5RS)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine) |
|
131086-22-1 |
詳細(xì)
|
| Lanolin (20 g) |
|
8006-54-0 |
詳細(xì)
|
| Magnesium Salicylate (200 mg) |
|
18917-95-8 |
詳細(xì)
|
| Manganese Sulfate (1 g) (AS) (DISCONTINUED) |
|
10034-96-5 |
詳細(xì)
|
| Maltose Monohydrate (500 mg) |
|
6363-53-7 |
詳細(xì)
|
| Mangiferin (15 mg) |
|
4773-96-0 |
詳細(xì)
|
| Mebendazole (200 mg) |
|
31431-39-7 |
詳細(xì)
|